SCHEMBL20206293

SCHEMBL20206293

C=C(C)C(C)NC(=O)/C=C/CN(C)C

nearest known ligand 0.37

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.33
TAS1R1 Q7RTX1 1/20 0.33
ITK Q08881 2/20 0.32
EGFR P00533 1/20 0.32
JAK3 P52333 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8031100 0.80 ALDH1A1 (0.50) CHRNB2CHRNB4CHRNA3CHRNA4TAS1R3
SCHEMBL25947506 0.80 ALDH1A1 (0.50) CHRNB2CHRNB4CHRNA3CHRNA4TAS1R3
SCHEMBL8031532 0.78 CHRNB2 (0.35) CHRNB2CHRNB4CHRNA3CHRNA4ITK
SCHEMBL23095392 0.77 CHRNB2 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4TAS1R3
SCHEMBL20807998 0.77 CHRNB2 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4TAS1R3
SCHEMBL19119593 0.77 CHRNB2 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4TAS1R3
SCHEMBL20132733 0.76 TAS1R3 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4TAS1R3
SCHEMBL20715990 0.75 CHRNB2 (0.38) CHRNB2CHRNB4CHRNA3CHRNA4TAS1R3
SCHEMBL24603042 0.73 TAS1R3 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4TAS1R3
SCHEMBL23336220 0.72 CHRNB2 (0.36) CHRNB2CHRNB4CHRNA3CHRNA4ITK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544970-B1 INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES THEREOF DANA FARBER CANCER INST INC (US) 2021-11-17 EP disclosed
WO-2018098367-A1 INHIBITORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-05-31 WO disclosed